Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
Acta Pharmacol Sin. 2021 Nov;42(11):1942-1950. doi: 10.1038/s41401-020-00602-3. Epub 2021 Feb 8.
Breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp) are co-located at blood-brain barrier (BBB) cells, preventing their substrates from entering brain. Accumulating evidence demonstrates that liver failure impairs P-gp and BCRP expression and function in the brain. In the current study, we investigated how liver failure influenced the expression and function of brain BCRP and P-gp in rats subjected to bile duct ligation (BDL). The function of BCRP, P-gp and BBB integrity was assessed using distribution of prazosin, rhodamine 123 and fluorescein, respectively. We showed that BDL significantly decreased BCRP function, but increased P-gp function without affecting BBB integrity. Furthermore, we found that BDL significantly downregulated the expression of membrane BCRP and upregulated the expression of membrane P-gp protein in the cortex and hippocampus. In human cerebral microvascular endothelial cells, NHCl plus unconjugated bilirubin significantly decreased BCRP function and expression of membrane BCRP protein, but upregulated P-gp function and expression of membrane P-gp protein. The decreased expression of membrane BCRP protein was linked to the decreased expression of membrane radixin protein, while the increased expression of membrane P-gp protein was related to the increased location of membrane ezrin protein. Silencing ezrin impaired membrane location of P-gp, whereas silencing radixin impaired membrane location of BCRP protein. BDL rats showed the increased expression of membrane ezrin protein and decreased expression of membrane radixin protein in the brain. We conclude that BDL causes opposite effects on the expression and function of brain BCRP and P-gp, attributing to the altered expression of membrane radixin and ezrin protein, respectively, due to hyperbilirubinemia and hyperammonemia.
乳腺癌耐药蛋白(BCRP)和 P-糖蛋白(P-gp)共同位于血脑屏障(BBB)细胞上,阻止其底物进入大脑。越来越多的证据表明,肝衰竭会损害大脑中 P-gp 和 BCRP 的表达和功能。在本研究中,我们研究了肝衰竭如何影响胆管结扎(BDL)大鼠大脑中 BCRP 和 P-gp 的表达和功能。分别使用普萘洛尔、罗丹明 123 和荧光素的分布来评估 BCRP、P-gp 和 BBB 完整性的功能。我们发现 BDL 显著降低了 BCRP 的功能,但增加了 P-gp 的功能,而不影响 BBB 的完整性。此外,我们发现 BDL 显著下调了皮质和海马中膜 BCRP 的表达,而上调了膜 P-gp 蛋白的表达。在人脑血管内皮细胞中,NHCl 加未结合胆红素显著降低了 BCRP 功能和膜 BCRP 蛋白的表达,但上调了 P-gp 功能和膜 P-gp 蛋白的表达。膜 BCRP 蛋白表达的降低与膜 radixin 蛋白表达的降低有关,而膜 ezrin 蛋白表达的增加与膜 P-gp 蛋白的膜定位增加有关。沉默 ezrin 会损害 P-gp 的膜定位,而沉默 radixin 会损害 BCRP 蛋白的膜定位。BDL 大鼠大脑中膜 ezrin 蛋白表达增加,膜 radixin 蛋白表达减少。我们得出结论,BDL 对大脑中 BCRP 和 P-gp 的表达和功能产生相反的影响,这归因于由于高胆红素血症和高氨血症,膜 radixin 和 ezrin 蛋白的表达发生改变。